Cardiology (all articles)
M-A: Omega-3 fatty acids supplementation is associated with increased risk of atrial fibrillation.
13 Oct, 2021 | 01:27h | UTCEffect of Long-Term Marine Omega-3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis – Circulation (link to abstract – $ for full-text)
Related:
Commentary on Twitter
#OriginalResearch Omega-3 fatty acid supplementation is associated with increased risk of #AFib in meta-analysis of RCTs https://t.co/knv0P0lmnC #AHAJournals @bagencer @Hopitaux_unige @CMAlbertEP @CedarsSinai @BrighamWomens @HarvardChanSPH @harvardmed pic.twitter.com/5VIklN8lm8
— Circulation (@CircAHA) October 6, 2021
Review: Optimal diet for cardiovascular and planetary health.
13 Oct, 2021 | 01:22h | UTCOptimal diet for cardiovascular and planetary health – Heart
AHA Scientific Statement: Medication Adherence and Blood Pressure Control.
12 Oct, 2021 | 00:09h | UTCNews release: Health system crucial to improve medication adherence for people managing hypertension – American Heart Association
Top Things to Know: Medication Adherence and Blood Pressure Control – American Heart Association
Commentary: Medication Adherence – Is It Really the Patient’s Fault? – American Heart Association
RCT: In stable patients who have undergone PCI for acute myocardial infarction, de-escalation from aspirin + ticagrelor to aspirin + clopidogrel after 1 month reduced bleeding events without increasing cardiovascular risk.
12 Oct, 2021 | 00:06h | UTCUnguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised trial – The Lancet (link to abstract – $ for full-text)
Heart-inflammation risk from Pfizer COVID vaccine is very low.
10 Oct, 2021 | 21:42h | UTCHeart-inflammation risk from Pfizer COVID vaccine is very low – Nature
Original studies:
Study suggests a 30-second interval between automated office blood pressure measurements is as accurate and reliable as a 60-second interval.
8 Oct, 2021 | 10:09h | UTCImpact of 30- Versus 60-Second Time Intervals Between Automated Office Blood Pressure Measurements on Measured Blood Pressure – Hypertension (link to abstract – $ for full-text)
Commentary on Twitter
Guidelines recommend a 60-sec pause between automated office BP measures. This study indicates a 30-sec interval not only saves time but is just as accurate and reliable. @spjuraschek @therealaishak @TimAndersonMD @jenniferlcluett https://t.co/A77bvhatZq pic.twitter.com/wdrUqZDWs4
— Hypertension (@HyperAHA) October 7, 2021
Large cohort study with over 2.5 million individuals showed the incidence of myocarditis after the Pfizer vaccine was 2.13 cases per 100,000 persons.
7 Oct, 2021 | 10:51h | UTCCommentary: Studies Highlight Rarity of Myocarditis With mRNA COVID-19 Vaccines – TCTMD
Related Study: Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel – New England Journal of Medicine
Commentaries on Twitter
Among 2.5 million patients who received the BNT162b2 mRNA vaccine in a large Israeli health care system, the incidence of myocarditis at 42 days was 2.13 cases per 100,000 persons. #Covid19vaccine #IDTwitter https://t.co/EzmsaW2u4Y pic.twitter.com/P95eUm8xo9
— NEJM (@NEJM) October 6, 2021
Just out in @NEJM: Two studies on myocarditis after vaccination with Pfizer
Among 2.5 million vaccinated:
– 54 cases of myocarditis
– 94% men, median 27 y.o.
– Most cases mild, only one fulminanthttps://t.co/xGf7rtwGfr— David Juurlink (@DavidJuurlink) October 6, 2021
Study with over 5.1 million vaccinated individuals showed the incidence of myocarditis after the receipt of the Pfizer vaccine was low and more common after the second dose in young male recipients.
7 Oct, 2021 | 10:49h | UTCMyocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel – New England Journal of Medicine
Commentary: Studies Highlight Rarity of Myocarditis With mRNA COVID-19 Vaccines – TCTMD
Related study: Myocarditis after Covid-19 Vaccination in a Large Health Care Organization – New England Journal of Medicine
Commentaries on Twitter
In an Israeli Ministry of Health database, 136 cases of myocarditis were detected among 5 million vaccinated persons. #Covid19vaccine #IDTwitter https://t.co/c1wLBCq8UN pic.twitter.com/D2DAGrIuXe
— NEJM (@NEJM) October 6, 2021
Two new @NEJM reports on Pfizer vaccine related myocarditis: very rare (~2 per 100,000) and usually mild; in-depth review of 190 cases, most cases were in males 16-29 years, 2nd dosehttps://t.co/nHgxXTgQ6ohttps://t.co/pchL0VDi4b pic.twitter.com/7pUxNy36Zo
— Eric Topol (@EricTopol) October 6, 2021
Sweden, Denmark pause Moderna COVID-19 vaccine for younger age groups.
7 Oct, 2021 | 10:45h | UTCSweden, Denmark pause Moderna COVID-19 vaccine for younger age groups – Reuters
Varied extent of mitral annular disjunction among cases with different phenotypes of mitral valve prolapse.
7 Oct, 2021 | 10:12h | UTC
Commentary on Twitter
Varied Extent of #MAD Among Cases With Different Phenotypes of #Mitral Valve #Prolapse ➡️ 3D #YesCCT ➡️ https://t.co/7q4GqIAZQd @JACCJournals @UCLA @argulian @purviparwani @MinnowWalsh @BakhshiHooman @MrinShettyMD @mividovich #JACCCaseReports @gina_lundberg @chiarabd @EstefaniaOS pic.twitter.com/6gVnaBg3cb
— Julia Grapsa MD, PhD (@JGrapsa) August 18, 2021
Cohort study: Adding a new antihypertensive to existing regimens is associated with greater blood pressure reductions than maximizing dose.
6 Oct, 2021 | 09:57h | UTCNews release: When blood pressure needs more control, what’s better: An additional drug or more of the same? – Michigan Medicine
Commentary on Twitter (thread – click for more)
Excited to see our paper in Annals today looking at blood pressure control regiments by adding multiple low dose meds vs. maxing dose then starting new meds. 🧵 https://t.co/3d4L2nZO4v
— Jeremy Sussman (@JeremySussman) October 5, 2021
Is salt good for you after all? The evidence says no.
6 Oct, 2021 | 08:52h | UTCIs salt good for you after all? The evidence says no – The Conversation
Related:
Systematic Review: Altered dietary salt intake for people with chronic kidney disease.
New WHO benchmarks help countries reduce salt intake and save lives.
RCT: Reduced-sodium added-potassium salt substitute reduces blood pressure in hypertensive patients
Potassium Enriched Salt Substitution Could Prevent a Large Number of Cardiovascular Deaths
Meta-Analysis: Effect of Reduction in Dietary Sodium on Blood Pressure Levels
Review: Inhibition of platelet aggregation after coronary stenting in patients receiving oral anticoagulation.
6 Oct, 2021 | 08:46h | UTC
Cohort study: Acute myocarditis following COVID-19 mRNA vaccination in adults aged 18 years or older is rare, and most cases are not severe.
5 Oct, 2021 | 10:07h | UTCEditorial: COVID-19 Messenger RNA Vaccination and Myocarditis—A Rare and Mostly Mild Adverse Effect
Commentary on Twitter
New report on very rare acute myocarditis after mRNA vaccination in age 18+
5.8 cases/million after 2nd dose, 0.8/million 1st dose, all cases fully resolved with conservative managementhttps://t.co/Mfh5ImiSpW @KPSCALnews @KPSCalResearch @JAMAInternalMed— Eric Topol (@EricTopol) October 4, 2021
AHA Scientific Statement: Diagnosis and management of patients with myocardial injury after noncardiac surgery.
5 Oct, 2021 | 09:01h | UTCNews Release: 1 in 5 adults has high levels of heart enzymes after any surgery, monitoring advised – American Heart Association
Commentary: AHA: More Screening Needed to Catch Myocardial Injury After Noncardiac Surgery – TCTMD
Clinical practice guideline: evidence, recommendations and algorithm for the preoperative optimization of anemia, hyperglycemia and smoking.
5 Oct, 2021 | 08:59h | UTC
M-A: Beta-blockers do not reduce the risk of major adverse cardiovascular events in patients with stable coronary artery disease without prior myocardial infarction or left ventricular dysfunction.
5 Oct, 2021 | 08:53h | UTCMeta-Analysis of the Usefulness of Beta-Blockers to Reduce the Risk of Major Adverse Cardiovascular Events in Patients With Stable Coronary Artery Disease Without Prior Myocardial Infarction or Left Ventricular Dysfunction – The American Journal of Medicine (link to abstract – $ for full-text)
Cohort study: Statin therapy initiation linked to increased risk of diabetes progression.
5 Oct, 2021 | 08:56h | UTCCommentaries:
Statin Therapy Initiation and Diabetes Progression – American College of Cardiology
Statin Initiation Linked to Greater Progression of Diabetes – HealthDay
Diabetes progression with initiation of statins – MedicalRessearch.com
Related:
Meta-Analysis: Medications that Reduce or Increase the Risk of New Onset Diabetes
Observational Study Points to an Increased Risk of Diabetes Among Patients Using Statins
Cohort Study: Statin Use Associated with a 38% Higher Risk of Incident Type 2 Diabetes
Commentary on Twitter
Large retrospective matched-cohort study found that #statin use was associated with a higher risk of #diabetes treatment escalation and an increased risk of #hyperglycemic complications https://t.co/lFLz7rVfpd
— JAMA Internal Medicine (@JAMAInternalMed) October 4, 2021
Systematic Review: Does testing for cancer in people with unprovoked blood clots in the legs and lungs reduce cancer- and blood clot-related death and illness?
3 Oct, 2021 | 22:33h | UTCOriginal article: Effect of testing for cancer on cancer‐ or venous thromboembolism (VTE)‐related mortality and morbidity in people with unprovoked VTE – Cochrane Library
RCT: Early computed tomography coronary angiography in patients with suspected acute coronary syndrome did not improve one year clinical outcomes.
3 Oct, 2021 | 22:35h | UTC
Commentary on Twitter
In this RCT, early CT coronary angiography in the emergency department for patients with suspected / provisional diagnosis of acute coronary syndrome had no effect on rate of death or subsequent non-fatal #heartattack at 1 year.@bmj_latest #Wondrmedicalhttps://t.co/usNKEGPDa4
— Prof Chris P Gale (@cpgale3) October 1, 2021
Coronary microvascular dysfunction: Considerations for diagnosis and treatment.
3 Oct, 2021 | 22:29h | UTCRelated:
Cohort study: Clinical characteristics and prognosis of patients with microvascular angina.
Position Paper on ‘Coronary Microvascular Dysfunction in Cardiovascular Disease’
Biomarkers of dairy fat intake, incident cardiovascular disease, and all-cause mortality: A cohort study, systematic review, and meta-analysis.
1 Oct, 2021 | 10:17h | UTCCommentaries:
People who eat more dairy fat have lower risk of heart disease, study suggests – CNN
M-A: Non-alcoholic fatty liver disease linked to increased risk of fatal and non-fatal cardiovascular events.
1 Oct, 2021 | 10:19h | UTCNon-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis – The Lancet Gastroenterology & Hepatology (link to abstract – $ for full-text)
Commentary on Twitter
https://twitter.com/LancetGastroHep/status/1440164633805918224
Cohort Study: Women treated with radiation therapy for left-sided breast cancer had over twice the risk of subsequent coronary artery disease compared with women treated with radiation therapy for right-sided breast cancer.
1 Oct, 2021 | 10:21h | UTCCommentaries:
CAD in Young Women After Radiation Therapy for Breast Cancer – American College of Cardiology
Commentary on Twitter
According to a study from #JACCCardioOnc, women with left-sided breast cancer undergoing radiation therapy between 1985 and 2008 had over twice the risk of subsequent #cvCAD compared to women with right-sided breast cancer. Learn more here: https://t.co/5q9tToSSRp #CardioOnc
— American College of Cardiology (@ACCinTouch) September 22, 2021
Cardiac troponin and defining myocardial infarction.
1 Oct, 2021 | 10:11h | UTCCardiac troponin and defining myocardial infarction – Cardiovascular Research


